@article{article, title = {{Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial}}, publisher = {{Public Library of Science (PLoS)}}, url = {{}}, year = {{2021}}, month = {{1}}, author = {{Jackson GH and Pawlyn C and Cairns DA and de Tute RM and Hockaday A and Collett C and Jones JR and Kishore B and Garg M and Williams CD and Karunanithi K et al}}, doi = {{10.1371/journal.pmed.1003454}}, volume = {{18}}, journal = {{PLOS Medicine}}, issue = {{1}}, note = {{Accessed on 2025/04/10}}}